PMR Publications >> Pharma >> Pharmaceutical market in Romania 2008



You have no products in your basket!

Pharmaceutical market in Romania 2008

Development forecasts for 2008-2010




Related products:

Pharma Poland Online
Central Europe Pharma News
Imaging diagnostics market in Poland 2010
Dietary supplements market in Romania 2010
Private healthcare market in Poland 2010
Price
(starting from)
  €1 600
add to basket
buy now
Date: 2008-10-02
Language: English
No. pages: 95
Delivery: PDF file
Pharmaceutical market in Romania 2008

  description    |    table of contents    |    table of graphs and tables    |    leaflet    |    free article    |    request more info 

Description:


Pharmaceutical market in Romania 2008 paints a comprehensive portrait of the Romanian pharmaceutical market and its path of growth and development during the period from 2002-2008. Data, analysis, solid, detailed forecasts for the period 2008-2010, along with pharmacy and hospital outlet activities and complete market value data presented by segment combine to help readers achieve a working knowledge of all facets of this complicated market.

Fresh and reliable data is carefully followed up with expert analysis of the market’s most influential factors, including: epidemiologist, demographics, and prevailing conditions in the Romanian health care and legal systems.

Pharmaceutical market in Romania 2008
also provides a comprehensive source of useful information concerning the market’s major players, their market shares and financials, along with detailed profiles of the ten top performers. Information gleaned through in-depth interviews with market experts enhances the value of this timely document, as does its astute analysis of data and market trends with regard to wholesale and retail trends in distribution and sales and the distributors and pharmacy chains engaged in these pharmaceutical market activities.


Report overview

Pharmaceutical market in Romania 2008 provides a comprehensive overview of the recent and current market segments, and analyses the effects of prevailing trends on the market as a whole as well as on the following segments, while forecasting trends for:

  • Rx, retail and hospital market
  • domestically produced and imported drugs 2002-2010
  • original and generic drugs 2002-2010.

Given the complicated nature of the wide variety of products available on the pharmaceutical market, this report breaks them down by therapeutic category, exploring the largest groups and defining their respective market shares. The groups include:

  • cardiovascular system drugs
  • central nervous system drugs drugs
  • used to treat the alimentary tract and metabolic issues
  • respiratory system drugs
  • anti-infectives
  • musculo-skeletal system drugs
  • genito-urinary system drugs
  • antineoplastics and immunomodulating agents
  • blood and blood forming organs
  • other ATC groups.

A study of the companies that manufacture, distribute and export pharmaceuticals in is vital to a comprehensive understanding of the market and its activities. In addition to a general overview of top companies 2002-2006, the report offers details on:

  • largest exporters, providing profiles of export activity
  • rankings of top 20 companies – 2007 and H1 2008
  • profiles of the largest ten companies.

Every market responds to trends, events and governmental activities that influence consumer habits and the conduct of business in general. Pharmaceutical market in Romania 2008 describes those demographic and epidemiological trends and health care and legal system conditions that affect the market, providing the latest information on:

  • population, aging and life expectancy trends
  • mortality and morbidity factors
  • prevalent trends affecting the health care system
  • drug expenditures
  • legislation and applicable institutions, EU
  • legislation, and market authorization
  • patent protection, advertising and product
  • pricing procedures.

Drug distribution in is affected by events and trends, and these are outlined in the report, along with anticipated conditions likely to prevail in 2008-2009. Profiles include:

  • pharmaceutical wholesalers – segment profile and financial results and characteristics of key players
  • pharmacy distribution – segment profile and financial results and characteristics of key players.

As a valuable enhancement, Pharmaceutical market in Romania 2008 features a directory of the 50 largest pharmaceutical companies active on the Romanian market. The report functions as a useful tool for:

  • companies currently active on the Romanian pharmaceutical market
  • companies considering market entry into Romanian pharmaceuticals
  • consulting and research companies and analytical institutes
  • government agencies, embassies and other trade organizations


Table of contents:


  1. Report methodology
  2. Executive summary
  3. Overview of the pharmaceutical market in Romania
    • Major trends and events on the Romanian pharmaceutical market
      • Major trends 2007-2008
      • Key events 2007-2008
      • Anticipated key trends and events 2008-2010
    • Size of the Romanian pharmaceutical market 2002-2010
      • Total market value in the years 2002-2010
      • Retail and hospital markets in the years 2002-2010
      • Rx market in the years 2002-2010
      • Domestically produced and imported drugs in the years 2002-2010
      • Original and generic drugs in the years 2002-2010
    • Average prices of drugs in Romania

  4. Pharmaceutical market by therapeutic groups
    • Cardiovascular system
    • Metabolism and alimentary tract
    • Anti-infectives
    • Central nervous system
    • Antineoplastic and immunostimulating agents
    • Respiratory system
    • Musculo-skeletal system
    • Blood and blood forming organs
    • Genito-urinary system
    • Dermatologicals

  5. Economic analysis of the Romanian pharmaceutical industry
    • General overview
    • Foreign trade
      • Actavis exports
      • Terapia Ranbaxy exports
      • Antibiotice exports
      • Zentiva (Sicomed) exports
      • Biofarm and LaborMed exports
    • Ranking of the largest drug manufacturers
    • Profiles of major market players
    • Major investments on the Romanian pharmaceutical market

  6. Distribution
    • Key events and trends on the distribution market 2002-2008
    • Anticipated trends on the distribution market 2008-2009
    • Pharmaceutical wholesalers
      • Subdivision profile
      • Key players
    • Pharmacy distribution
      • Subgroup profile
        • Geographical dispersal
        • General rules for running a pharmacy
        • Number and categories of pharmacies
    • Key players
    • Non-pharmacy sales
    • Online sales

  7. Factors which influence the Romanian pharmaceutical market
    • Demographic trends
      • Population
      • Ageing of society
      • Life expectancy
    • Epidemiological trends
      • Mortality
      • Morbidity
    • Healthcare system
    • Spending on drugs
    • Legal environment
      • Main legislation and institutions governing pharmaceuticals in Romania
      • Market authorisation
        • General rules
        • Mutual Recognition Procedure
        • Fees for Market Authorisation
      • Patent protection
      • Advertising of medicines
      • Pricing procedures
        • VAT and duties
        • Retail and wholesale margins
        • Reimbursement system

  8. List of graphs
  9. List of tables
  10. About PMR
  11. Contact PMR

List of graphs and Tables:


List of graphs

  1. Value (€ m) and y-o-y growth of the pharmaceutical market in Romania, 2002-2010
  2. Value (€ m) and y-o-y change of the pharmaceutical market in Romania, 2002-2010
  3. Value (€ m) and y-o-y change of the retail pharmaceutical market in Romania, 2002-2010
  4. Value (€ m) and y-o-y change of the hospital pharmaceutical market in Romania, 2002-2010
  5. Share of retail and hospital market as a proportion of total pharmaceutical market value in Romania, 2002-2010
  6. Value (€ m) and y-o-y change of the retail Rx market in Romania, 2002-2010
  7. Comparison of y-o-y growth of Rx and OTC sales in Romania, 2003-2007
  8. Value (€ m) and y-o-y change in imported drugs in Romania, 2002-2010
  9. Value (€ m) and y-o-y change of domestic drugs in Romania, 2002-2010
  10. Share of domestic and foreign drugs as a proportion of total pharmaceutical market value in Romania, 2002-2010
  11. Share of innovative and generic drugs as a proportion of total pharmaceutical market value in Romania, 2003-2010
  12. Value (€ m) and y-o-y change of generic drugs in Romania, 2002-2010
  13. Value (€ m) and y-o-y change of non-generic drugs in Romania, 2002-2010
  14. Average prices of drugs in Romania (€ per one package), by therapeutic category, 2007
  15. Average prices of drugs in selected EU countries (€ per one tablet), 2008
  16. Pharmaceutical market by ATC categories in terms of value in Romania, 2007
  17. Pharmaceutical market by ATC categories in terms of value in Romania, Q1 2007-Q1 2008
  18. Sales (RON m) and y-o-y increase in cardiovascular drugs in Romania, 2005-2010
  19. Top 10 companies in cardiovascular drug subgroup, by value, Q1 2008
  20. Sales (RON m) and y-o-y change in drugs used in alimentary tract and metabolic diseases in Romania, 2005-2010
  21. Sales (RON m) and y-o-y increase of anti-infectives in Romania, 2005-2010
  22. Sales (RON m) and y-o-y increase in drugs used for CNS diseases in Romania, 2005-2010
  23. Sales (RON m) and y-o-y increase in antineoplastic and immunostimulating agents in Romania, 2005-2010
  24. Sales (RON m) and y-o-y change in drugs used for respiratory system diseases in Romania, 2005-2010
  25. Sales (RON m) and y-o-y change in drugs used for musculo-sceletal system diseases in Romania, 2005-2010
  26. Sales (RON m) and y-o-y change in drugs used for blood and blood forming organs diseases in Romania, 2005-2010
  27. Sales (RON m) and y-o-y change in drugs used to treat genito-urinary system diseases in Romania, 2005-2010
  28. Sales (RON m) and y-o-y change in dermatologicals in Romania, 2005-2010
  29. Actavis Romania export sales (€ m), 2006-2008
  30. Terapia Ranbaxy export sales (€ m), 2006-2007
  31. Antibiotice export sales (€ m), 2006-2008
  32. Shares of top 10 manufacturers on the pharmaceutical market in Romania, by value, 2007
  33. Shares of top 10 manufacturers on the pharmaceutical market in Romania, by value, H1 2008
  34. GSK sales revenue (RON m) and y-o-y growth in Romania, 2005-2007
  35. Novartis sales revenue (RON m) and y-o-y growth in Romania, 2005-2007
  36. Roche sales revenue (RON m) and y-o-y growth in Romania, 2005-2007
  37. Sanofi-Aventis sales revenue (RON m) and y-o-y growth in Romania, 2005-2007
  38. Servier sales revenue (RON m) and y-o-y growth in Romania, 2005-2007
  39. Pfizer sales revenue (RON m) and y-o-y change in Romania, 2005-2007
  40. Terapia Ranbaxy sales revenue (RON m) and y-o-y growth in Romania, 2005-2007
  41. Zentiva sales revenue (RON m) and y-o-y change in Romania, 2005-2007
  42. Antibiotice sales revenue (RON m) and y-o-y change in Romania, 2005-2007
  43. Krka sales revenue (RON m) and y-o-y growth in Romania, 2005-2007
  44. Market shares of the largest pharmaceutical distributors in Romania, retail market, 2007
  45. Market shares of the largest pharmaceutical distributors in Romania, hospital market, 2007
  46. Market share of the largest pharmaceutical distributors in Romania, total market, 2007
  47. Mediplus revenues (€ m) in Romania, 2002-2008
  48. Relad Group turnover (€ m) in Romania, 2006-2007
  49. Fildas Group turnover (€ m) in Romania, 2006-2007
  50. Polisano’s turnover (€ m) in Romania, 2006-2007
  51. Farmexpert annual turnover (€ m) in Romania, 2006-2008
  52. Farmexim turnover (€ m) in Romania, 2006-2008
  53. Largest pharmacy chains in Romania (number of pharmacies), 2008
  54. Population of Romania (’000), 1989-2007
  55. Proportion of age groups in population in Romania, 2007
  56. Percentage of deaths caused by cardiovascular diseases in Romania, 1989-2006
  57. Percentage of deaths caused by tumours in Romania, 1989-2006
  58. Percentage of deaths caused by respiratory diseases in Romania, 1989-2006
  59. Percentage of deaths caused by injury, poisoning and other external causes in Romania, 1989-2006
  60. Percentage of deaths caused by digestive system diseases in Romania, 1989-2006
  61. Morbidity in Romania (% of total diseases), 2006
  62. Expenditure on health (€ m) and y-o-y change in Romania, 2000-2006
  63. Per capita expenditure on health (€) and y-o-y change in Romania, 2000-2006
  64. Per capita drug spending ($) in selected CEE countries, 2006

List of tables

  1. Best selling generics in Romania, October 2006-September 2007
  2. Average prices of drugs in Romania (€ per one package), by distribution channel and availability category, 2007
  3. Best selling cardiovascular drugs in Romania and their market shares, Q1 2008
  4. Sales value of the 20 largest manufacturers on the pharmaceutical market in Romania (RON, €), 2007
  5. Sales value of the 20 largest manufacturers on the pharmaceutical market in Romania (RON, €), Q1 2008 and 2008
  6. Other causes of deaths in Romania (number of deaths per 100,000 inhabitants), 1989-2006
  7. MRP in Romania, 2008
  8. Tariffs for the administration of the Evaluation-Authorisation Department in Romania, 2008
  9. Retail margins on drugs in Romania, 2008

Request for more information :


In order to receive more detailed information of:

Pharmaceutical market in Romania 2008 Development forecasts for 2008-2010

please fill in the form below.

None of this information will be disclosed to third parties.
To be assured that we take your privacy seriously, please read our Privacy Policy.

Please fill out all the fields correctly. Information will only be provided if forms are adequately completed.


(optional):
FREE online demonstration of the product (15 minutes interactive teleconference)
PMR reserves the right to refuse and / or withdraw this service without justification or prior notification

Email:
In order to make sure you receive our information, please add our email address: info@pmrcorporate.com to the list of safe sources in your company. Please contact your IT department for details. Thank you.

Choose sector of interest: (You must specify at least one sector)

construction: retail: pharma: it & telecom: general economy:

Additional:
(specify)

Please read our Privacy Policy.

Download white paper:




  description    |    table of contents    |    table of graphs and tables    |    leaflet    |    free article    |    request more info 

Copyright © 2010 PMR
All rights reserved.

 
PMR PMR Consulting PMR Research Polish Business Market China Business Market Careers at PMR
Retail Poland Retail Russia Central Europe Retail Pharma market Poland Pharma market Central Europe
Construction Russia Construction Poland Construction Ukraine Construction market CEE Rynek Budowlany
Telecoms Poland Telecoms Russia CEE Telecoms Business market Central Europe Analiza Rynku Links